Studying cancer biology and therapeutic targets using PET technology: opening an extraordinary option
In vivo imaging is at the heart of preclinical research into cancer biology and treatment, with advances in technology delivering tools that are ever more powerful, accurate and easy-to-use. In this webinar, you will hear about one lab’s experience of integrating one such technology – Bruker’s preclinical PET system – into a hospital-based small-animal imaging lab, and how it has assisted their paradigm-shifting research into cancer cell biology.
What you will discover
Professor Gianmario Sambuceti will describe his team’s experience of establishing an experimental small-animal imaging lab on-site at the IRCCS San Martino, one of Europe’s largest hospitals, using Bruker PET technology. Professor Sambuceti and his team identified a previously unknown way of processing glucose in cancer cells through the application of microPET imaging. The findings shed new light on established models of cell metabolism, and could lead to new options for the diagnosis and treatment of cancer. During this webinar, Professor Sambuceti will explain how the team used Bruker PET technology in their research to study how glucose is used by cancer cells. He will describe the team’s findings and outline how the particular advantages of PET imaging helped overcome obstacles to this kind of research in the past.
See you on line!
Your Webinar Team
注册请点击“阅读原文”